The Power of a Platform Company with Josh Mandel-Brehm
Raising Health
00:00
Using a Screen to Target a Regulatory RNA in a Cell Type?
The part that's become an in-silical exercise for us is exactly what you said. We can literally go from a regulatory RNA to a potential human clinical lead in a matter of months, if you will. But we've basically been navigating this the last four years and built the conditions to be able to study this and understand it. And so ultimately, it is one very efficient.
Play episode from 14:13
Transcript
